Cause of death after transcatheter aortic valve implantation

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 7, 2014, Pages

  Van Mieghem, Nicolas M ^a   Van Der Boon, Robert M ^a   Nuis, Rutger Jan ^a   Schultz, Carl ^a   Van Geuns, Robert Jan ^a   Serruys, Patrick W ^a   Kappetein, Arie Pieter ^a   Van Domburg, Ron T ^a   De Jaegere, Peter P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

aortic stenosis; cause of death; VALV; Valvular heart disease

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OUTCOME ASSESSMENT; SEPSIS; SURGICAL RISK; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTIC VALVE STENOSIS; EPIDEMIOLOGY; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; INCIDENCE; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRENDS; VERY ELDERLY;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84901002401     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24597     Document Type: Article

References (18)

1. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention 2008; 4: 193-199.
2. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince SL, Mack MJ,. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008; 135: 180-187.
3. van Gameren M, Piazza N, Bogers AJ, Takkenberg JJ, Kappetein AP,. How to assess risks of valve surgery: Quality, implementation and future of risk models. Heart 2009; 95: 1958-1963.
4. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
5. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
6. Reynolds MR, Magnuson EA, Lei Y, et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011; 124: 1964-1972.
7. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: Early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011; 32: 191-197.
8. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: First results from a multi-centre real-world registry. Eur Heart J 2011; 32: 198-204.
9. Bosmans JM, Kefer J, De Bruyne B, Herijgers P, Dubois C, Legrand V, Verheye S, Rodrigus I,. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: Results of the Belgian national registry. Interact Cardiovasc Thorac Surg 2011; 12: 762-767.
10. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55: 1080-1090.
11. Lefevre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011; 32: 148-157.
12. Bleiziffer S, Mazzitelli D, Opitz A, Hettich I, Ruge H, Piazza N, Lange R,. Beyond the short-term: Clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients. J Thorac Cardiovasc Surg 2011; 143: 310-317.
13. Buellesfeld L, Gerckens U, Schuler G, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol 2011; 57: 1650-1657.
14. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: The European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011; 124: 425-433.
15. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122: 62-69.
16. Ussia GP, Barbanti M, Petronio AS, et al. Transcatheter aortic valve implantation: 3-Year outcomes of self-expanding CoreValve prosthesis. Eur Heart J 2012; 33: 969-976.
17. Lee SJ, Lindquist K, Segal MR, Covinsky KE,. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006; 295: 801-808.
18. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK,. Prognostic indices for older adults: A systematic review. JAMA 2012; 307: 182-192.